Annual report [Section 13 and 15(d), not S-K Item 405]

NOTES PAYABLE (Details Narrative)

v3.25.0.1
NOTES PAYABLE (Details Narrative) - USD ($)
1 Months Ended 12 Months Ended
Aug. 01, 2024
Mar. 06, 2024
Jun. 01, 2023
Jul. 28, 2020
Nov. 30, 2023
Nov. 30, 2022
Dec. 31, 2024
Dec. 31, 2023
Debt Instrument [Line Items]                
Interest Expense, Debt             $ 1,800,000 $ 3,800,000
Debt Instrument, Unamortized Discount             0 2,954,000
Lenders [Member]                
Debt Instrument [Line Items]                
Debt Instrument, Unamortized Discount             3,000,000  
Insurance Policy [Member]                
Debt Instrument [Line Items]                
Prepaid Expense, Current             0 $ 300,000
Loan Agreement [Member]                
Debt Instrument [Line Items]                
Notes payable         $ 400,000 $ 500,000    
Monthly loan payments term         ten-month period nine-month period    
Debt Instrument, Periodic Payment         $ 39,000 $ 51,000    
Debt Instrument, Interest Rate, Stated Percentage         8.15% 5.40%    
Loan Agreement [Member] | K2 HealthVentures LLC [Member]                
Debt Instrument [Line Items]                
Debt Conversion, Converted Instrument, Amount   $ 1,100,000 $ 900,000       5,000,000  
Conversion price per share   $ 7.875 $ 4.5          
Warrants to purchase shares of common stock, exercised   142,857 194,444 2,873        
Exercise price of warrants       $ 208.8        
Loan Agreement [Member] | K2 HealthVentures LLC [Member] | Share-based Payment Arrangement, Tranche One [Member]                
Debt Instrument [Line Items]                
Secured debt       $ 20,000,000        
Amended loan agreement                
Debt Instrument [Line Items]                
Debt Instrument Periodic Payment Interest $ 1,600,000              
Final payment 1,600,000              
Loan Maturity Final Amount 11,800,000              
DebtInstrumentOutstandingPrincipalAmount $ 10,100,000              
Amended loan agreement | K2 HealthVentures LLC [Member]                
Debt Instrument [Line Items]                
Debt Instrument, Description       Interest payments were made monthly and accrued at a variable annual rate equal to the greater of (i) 8.5% and (ii) the rate of interest noted in The Wall Street Journal, Money Rates section, as the “Prime Rate” plus 5.25%.        
Debt 1a [Member] | Loan Agreement [Member] | K2 HealthVentures LLC [Member] | Minimum [Member]                
Debt Instrument [Line Items]                
Debt Conversion, Converted Instrument, Amount             $ 900,000  
Conversion price per share             $ 4.5  
Debt 1b [Member] | Loan Agreement [Member] | K2 HealthVentures LLC [Member]                
Debt Instrument [Line Items]                
Debt Conversion, Converted Instrument, Amount             $ 1,100,000  
Conversion price per share             $ 7.875  
Debt 2 [Member] | Loan Agreement [Member] | K2 HealthVentures LLC [Member]                
Debt Instrument [Line Items]                
Debt Conversion, Converted Instrument, Amount             $ 3,000,000  
Conversion price per share             $ 282